Press release
Diabetic Retinopathy Market Size Forecasted To Achieve $12.56 Billion By 2029 With Steady Growth
Diabetic Retinopathy Market Size
What Is the Diabetic Retinopathy Market Size and Projected Growth Rate?
The market size of diabetic retinopathy has experienced robust growth in the past few years. The market is poised to increase from $8.61 billion in 2024 to $9.29 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. Factors such as an aging population, a surge in the cases of diabetes, increased cognizance of diabetic retinopathy, advancing healthcare infrastructure, and escalating healthcare expenditure are credited for the growth during the historic period.
Expectations are high for the diabetic retinopathy market to experience robust expansion in the coming years, with a projected growth to $12.56 billion by 2029 and a compound annual growth rate (CAGR) of 7.8%. This anticipated growth during the forecast period can be attributed to such factors as the implementation of personalized medicine techniques, the broadening scope of telemedicine services, innovations in therapeutic interventions, point-of-care testing practices, and remote patient oversight. Key trends that are likely to be observed during the forecast period encompass precision medicine in the therapeutic realm of diabetic retinopathy, an augmented emphasis on early recognition and prevention, proliferation of teleophthalmology services, a boost in gene therapy studies, and ongoing progress in retinal imaging technology.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12187
What Are the Major Segments in the Diabetic Retinopathy Market?
The diabetic retinopathy market covered in this report is segmented -
1) By Type: Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy
2) By Treatment: Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photocoagulation, Vitreoretinal Surgery
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Proliferative Diabetic Retinopathy (PDR): Neovascularization, Vitreous Hemorrhage, Tractional Retinal Detachment
2) By Non-Proliferative Diabetic Retinopathy (NPDR): Mild NPDR, Moderate NPDR, Severe NPDR
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12187&type=smp
What Are The Driving Diabetic Retinopathy Market Evolution?
The surge in diabetes cases is anticipated to fuel the expansion of the diabetic retinopathy market. Diabetes is a long-lasting metabolic disorder that results in elevated glucose levels in the blood. The escalating occurrence of diabetes is predominantly stimulated by factors such as excess weight, obesity, heredity, and sedentary lifestyle. Too much sugar in the blood can harm the retina of individuals with diabetes, an eye component responsible for detecting light and transmitting signals to the brain via an optic nerve. For instance, the Office for Health Improvement and Disparities, a UK government agency, noted in March 2024 that the rate of individuals with type 1 diabetes undergoing all eight recommended care processes amplified by 22% between March 2022 and March 2023, while an increase of 21% was witnessed in type 2 diabetes cases. The percentage of individuals achieving the target HbA1c levels also hit 37.9%, a peak value ever recorded by the National Diabetes Audit. Thus, the burgeoning prevalence of diabetes is stimulating the development of the diabetic retinopathy market.
Which Firms Dominate The Diabetic Retinopathy Market Segments?
Major companies operating in the diabetic retinopathy market include Pfizer Inc., F-Hoffmann-La Roche Ltd., Abbvie Inc., Bayer AG, Novartis AG, Ellex Medical Lasers Ltd., Abbott Laboratories Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Icon Bioscience Inc., Allergan plc., Genentech Inc., Aurobindo Pharma, Santen Pharmaceutical Co. Ltd., Carl Zeiss Meditec AG, Valeant Pharmaceuticals International Inc., Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co. Ltd., IRIDEX Corporation, Alimera Science Inc., Kowa Company Ltd., Ocular Therapeutix Inc., Aerpio Pharmaceuticals Inc., Kodiak Sciences Inc., Oxurion NV, Graybug Vision Inc., Ampio Pharmaceuticals Inc.
What Trends Are Expected to Dominate the Diabetic Retinopathy Market in the Next 5 Years?
The advancement in technology is a prominent trend gaining traction in the diabetic retinopathy market. In order to maintain their stronghold in the large volume parenteral market, crucial corporations are leveraging these new technologies. For instance, Baxter International Inc., a healthcare firm based in the US, launched the Welch Allyn RetinaVue 100 Imager PRO in South Korea in July 2022. These innovations aim to facilitate the identification of diabetic retinopathy in primary care environments. RetinaVue has been demonstrated to enhance patient adherence to potentially life-saving annual diabetic retinal exams (DREs) by conducting quick and unintrusive screenings during regular primary care appointments.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/diabetic-retinopathy-global-market-report
Which Is The Largest Region In The Diabetic Retinopathy Market?
North America was the largest region in the diabetic retinopathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic retinopathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Diabetic Retinopathy Market?
2. What is the CAGR expected in the Diabetic Retinopathy Market?
3. What Are the Key Innovations Transforming the Diabetic Retinopathy Industry?
4. Which Region Is Leading the Diabetic Retinopathy Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Retinopathy Market Size Forecasted To Achieve $12.56 Billion By 2029 With Steady Growth here
News-ID: 3996865 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Diabetic
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Leading Element Driving Change in the Diabetic Footwear Market in 2025: Rising D …
Which drivers are expected to have the greatest impact on the over the diabetic footwear market's growth?
The surge in people with diabetes will spur the expansion of the diabetic footwear market in the future. Diabetes, characterised by high blood sugar levels, is a long-term health issue. Diabetic footwear can prevent severe foot-related issues caused by diabetes and offer several advantages such as enhanced blood flow, ample space for the toes,…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
